New Nanoparticles Generate Hydrogen to Fight Liver Cancer

Authors
Journal
Advanced Healthcare Materials
Year
DOI
10.1002/adhm.202503568
Study Type
Cell Culture
Outcome
Positive
Peer Reviewed
Yes
Country
China
Health Condition
Liver Cancer
Body System
Hepatic

TL;DR

A smart nanoparticle therapy uses hydrogen and reactive oxygen bursts to kill liver tumors while boosting immune responses and minimizing damage.

Key Finding

Engineered nanoparticles activated by microwave energy generated hydrogen radicals in oxygen-poor tumor regions while simultaneously clearing excess damaging molecules afterward, resulting in 94.8% tumor suppression and significantly increased immune cell infiltration in laboratory studies.

Summary

This study developed specialized nanoparticles (tiny engineered particles) designed to fight liver tumors using microwave energy. The nanoparticles generate hydrogen radicals and reactive oxygen species (unstable molecules that damage cells) in low-oxygen tumor areas while also cleaning up excess of these damaging molecules afterward, which helps immune cells work better. In laboratory tests, the treatment suppressed tumor growth by 94.8% and increased immune cell activity.

Practical Takeaway

This is very early-stage laboratory research using cell cultures and engineered nanoparticles—not hydrogen water as typically consumed. While the results are promising for future cancer therapy development, this work is far from human application and does not directly inform the safety or effectiveness of drinking hydrogen water for general health.

Abstract

Reactive Oxygen Species (ROS) exhibit a paradoxical dual role in tumor therapy. Tumor hypoxia restricts therapeutic ROS generation, while excessive secondary ROS post-ablation suppresses T-cell function yet promotes M1 macrophage polarization. Semiquinone radical-doped reduced polydopamine nanoparticles (PDAred) loaded is developed with resiquimod (R848) (PDAred@R848) via π-π stacking. Reduction enriches the nanoparticles with semiquinone radicals, enhancing dielectric properties and dipole polarization under electromagnetic effects. This nanoparticle enables the specific hydrogen radicals (H•)/ROS generation in oxygen-heterogeneous tumor under microwave irradiation. In microwave dynamics therapy (MDT) phase, PDAred converts protons (H⁺) to H• under microwave irradiation in hypoxic regions, targeting cytochrome c and inducing tumor cell apoptosis and immunogenic cell death; PDAred establishes an internal electric field under microwave, facilitating electron-hole separation to produce ROS and trigger ferroptosis in normoxic regions. In post-MDT phase, PDAred's intrinsic polyphenols scavenge excess secondary ROS produced by damaged cells, alleviating immunosuppression. Compared with blank control, PDAred@R848 increased CD4⁺/CD8⁺ T-cell infiltration (6.4-fold) and M1 macrophage polarization (2.5-fold M1/M2 ratio elevation). Pro-inflammatory cytokines are significantly reduced, and tumor volume is suppressed by 94.8%. This study proposes an innovative dual-action mechanism coordinating oxygen-adapted radical generation with secondary ROS clearance to reprogram redox/immune homeostasis for effective liver tumor eradication.